BioTuesdays

FDA approves Pfenex osteoporosis drug

The FDA approved Pfenex’s (NASDAQ:PFNX) PF708 for the treatment of osteoporosis in patients at high risk of fracture. “The FDA’s approval of PF708 marks a major milestone in Pfenex’s history as our first approved...

Heron resubmits NDA for postoperative pain drug

Heron Therapeutics (NASDAQ:HRTX) resubmitted its NDA for HTX-011 – a dual-acting combination of the local anesthetic bupivacaine and the nonsteroidal anti-inflammatory drug, meloxicam – to the FDA.  The resubmission was...